Tianjin Tianyao Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BUDESONIDE USP BULK API, with a corresponding US DMF Number 32195.
Remarkably, this DMF maintains an Active status since its submission on October 25, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 30, 2018, and payment made on July 17, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II